Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Metformin  COVID-19 treatment studies for Metformin  C19 studies: Metformin  Metformin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis
Lukito et al., Diabetes & Metabolic Syndrome: Clinical Research & Reviews, doi:10.1016/j.dsx.2020.11.006 (meta analysis)
Lukito et al., The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and.., Diabetes & Metabolic Syndrome: Clinical Research & Reviews, doi:10.1016/j.dsx.2020.11.006 (meta analysis)
Nov 2020   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Meta analysis of 9 studies showing lower mortality with metformin use.
Currently there are 61 metformin studies and meta analysis shows:
OutcomeImprovement
Mortality32% lower [27‑37%]
Ventilation32% lower [6‑50%]
ICU admission17% lower [2‑29%]
Hospitalization19% lower [10‑28%]
Cases0% fewer [-15‑14%]
Lukito et al., 11 Nov 2020, peer-reviewed, 6 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperMetforminAll
Abstract: Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (2020) 2177e2183 Contents lists available at ScienceDirect Diabetes & Metabolic Syndrome: Clinical Research & Reviews journal homepage: www.elsevier.com/locate/dsx The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis Antonia Anna Lukito a, *, 1, Raymond Pranata b, 1, Joshua Henrina c, Michael Anthonius Lim a, Sherly Lawrensia d, Ketut Suastika e a Department of Cardiology and Vascular Medicine, Siloam Hospitals Lippo Village, Tangerang, Indonesia Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia RSUD Balaraja, Tangerang, Indonesia d Ken Saras General Hospital, Semarang, Indonesia e Head, Division of Endocrinology and Metabolism Department of Internal Medicine, Faculty of Medicine, Udayana University. Denpasar, Bali, Indonesia Denpasar, Bali, Indonesia b c a r t i c l e i n f o a b s t r a c t Article history: Received 29 October 2020 Received in revised form 4 November 2020 Accepted 6 November 2020 Background and aims: Diabetes is one of the most common comorbidities, and it is associated with poorer outcomes in patients with coronavirus disease 2019 (COVID-19). Preliminary findings showed that mortality was reduced in those who consume metformin compared to those who did not, and given its low cost and widespread availability; metformin is an attractive and potential agent to mitigate excessive risk in diabetic populations. Methods: Several medical databases (Pubmed, EuropePMC, EBSCOhost, Proquest, Cochrane library) and two health-science preprint servers (preprint.org and Medrxiv) were systematically searched for relevant literature. Results: Nine studies with 10,233 subjects were included in the qualitative and quantitative synthesis. Meta-analysis showed that metformin is associated with lower mortality in pooled non-adjusted model (OR 0.45 [0.25, 0.81], p ¼ 0.008; I2: 63.9%, p ¼ 0.026) and pooled adjusted model (OR 0.64 [0.43, 0.97], p ¼ 0.035; I2: 52.1%, p ¼ 0.064). Conclusion: The analysis showed that metformin consumption was associated with lower mortality. Randomized controlled trials are needed to confirm this finding. © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. Keywords: COVID-19 SARS-CoV-2 Diabetes melitus Metformin Mortality
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit